Minnesota 2023-2024 Regular Session

Minnesota Senate Bill SF168

Introduced
1/11/23  
Refer
1/11/23  
Refer
1/25/23  
Refer
2/27/23  
Refer
3/15/23  
Refer
3/20/23  

Caption

Excessive price increases by manufacturers prohibition to generic or off-patent drugs

Companion Bills

MN HF17

Similar To Generic or off-patent drugs; excessive price increases prohibited, attorney general authorized to take action against price increases, sale withdrawal prohibited, prescription drug affordability board and advisory council established, prescription drug cost reviews and remedies provided, and money appropriated.

Previously Filed As

MN A4184

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

MN SF4250

Drug price increases restrictions elimination provision and sale or distribution withdraw notice requirement elimination provision

MN S0486

Establishes a process whereby large drug manufacturers, may be penalized for prescription drug price increases where there is no, or inadequate, new evidence to support the price increase.

MN HB2645

essential drugs; price increases; limits

MN SB1797

essential drugs; price increases; limits.

MN HB2757

Essential drugs; price increases; limits

MN SB1402

Essential drugs; price increases; limits.

MN HF2703

Prohibition extended on manufacturers interfering with access to 340B drugs.

MN SF2959

Manufacturers interfering with access to 340B drugs prohibition extension

MN H7950

Regulates price increases for prescription drugs.

Similar Bills

No similar bills found.